Navigation Links
Covance Announces Monte Jarvis as Vice President of Global Data Management and Biostatistics for Periapproval Services
Date:6/2/2009

- Data management, biostatistics expert adds more than 25 years of experience to support growing demand for periapproval services -

PRINCETON, N.J., June 2 /PRNewswire/ -- Covance Inc. today announced Monte Jarvis as vice president of global data management and biostatistics for periapproval services. With more than 25 years of experience in scientific computing, biostatistics, bioinformatics, programming, and global data management, Jarvis will oversee data management and biostatistics for Phase IIIb/IV clinical studies, patient registries, and observational studies.

"We are excited to welcome Monte and look forward to leveraging his expertise to help increase our access and utilization of emerging technologies and healthcare data structures," said Hani Zaki, vice president and general manager, periapproval services, Covance. "His extensive experience will improve collaborations and efficiencies to enhance our delivery of REMS and other Phase IIIb/IV services."

With a diverse background that includes roles in academia, Pharma/biotech, and contract research organizations (CROs), Jarvis will help support increased demand for periapproval services, including risk evaluation and mitigation strategies (REMS), resulting from the Food and Drug Administration Amendment Acts (FDAAA) of 2007.

Jarvis joins Covance from Centocor, where he oversaw biostatistics and data management for the oncology and device divisions. A certified system, network and database administrator, he has helped build scientific and enterprise computing environments and spearheaded corporate adoption of emergent data technologies and standards for pharmaceutical/biotechnology companies and CROs.

Jarvis holds bachelors degrees in Mathematics, Computer Science, and the Humanities and a master's degree in Demography (Actuarial Statistics). He completed additional coursework at the Wharton School of Business and was a funded PhD candidate at the University of Pennsylvania until leaving academia for industrial research and development. He continues to study new technologies and their application to patient health and wellness.

Covance's periapproval services include Phase IIIb/IV clinical studies, registries and observational studies, risk management, epidemiology, and product safety services. As the leader in the design and implementation of Risk Evaluation and Mitigation Strategies (REMS), Covance offers innovative tools and methodologies for complete post-approval support.

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,800 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release, which are not historical facts, are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to an qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss of large contracts, and other factors described in the Company's filings with the Securities and Exchange Commission.Covance and the Covance are registered service marks of Covance in the United States and other countries.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Covance to Present at the UBS Global Life Sciences Conference
2. Covance Elects Dr. Gary E. Costley to Board of Directors
3. Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRTs Centralized Cardiac Safety Services
4. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
5. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
6. Covance and Care Partner on Rwanda Early Childhood Development Initiative
7. Wendel Barr Appointed Chief Operating Officer of Covance
8. Covance to Present at 26th Annual JPMorgan Healthcare Conference
9. Covance to Present at UBS Global Healthcare Services Conference
10. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
11. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: